Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:AstraZeneca
|
| gptkbp:acquisitionYear |
2007
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
biologics
vaccines antibody therapeutics |
| gptkbp:foundedYear |
1988
|
| gptkbp:founder |
gptkb:Wayne_T._Hockmeyer
|
| gptkbp:headquartersLocation |
gptkb:Gaithersburg,_Maryland,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
MedImmune
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:FluMist
gptkb:Synagis |
| gptkbp:numberOfEmployees |
approximately 3,000 (at time of acquisition)
|
| gptkbp:parentCompany |
gptkb:AstraZeneca
|
| gptkbp:researchArea |
infectious diseases
oncology autoimmune diseases |
| gptkbp:status |
gptkb:subsidiary
|
| gptkbp:website |
https://www.medimmune.com/
|
| gptkbp:bfsParent |
gptkb:Gaithersburg,_Maryland,_United_States
gptkb:AstraZeneca gptkb:Gaithersburg,_Maryland |
| gptkbp:bfsLayer |
5
|